Table 2.
Association of osteosarcoma risk with relative leukocyte telomere length dichotomized at the median
Case n (%) | Control*n (%) | OR† (95% CI) | P | ||
---|---|---|---|---|---|
Overall‡ | Short | 58 (59.2) | 35 (50.7) | 1.39 (0.70-2.76) | 0.67 |
Long | 40 (40.8) | 34 (49.3) | (ref) | ||
Age§ | |||||
≤15 | Short | 8 (33.3) | 8 (47.1) | 0.55 (0.15-1.98) | 0.36 |
Long | 16 (66.7) | 9 (52.9) | (ref) | ||
16-30 | Short | 22 (51.2) | 11 (33.3) | 2.15 (0.83-5.54) | 0.11 |
Long | 21 (48.8) | 22 (66.7) | (ref) | ||
31-45 | Short | 14 (93.3) | 9 (81.8) | 2.80 (0.20-40.06) | 0.45 |
Long | 1 (6.7) | 2 (18.2) | (ref) | ||
46-77 | Short | 14 (87.5) | 7 (87.5) | 1.42 (0.09-23.36) | 0.81 |
Long | 2 (12.5) | 1 (12.5) | (ref) | ||
Gender¶ | |||||
Male | Short | 31 (55.4) | 22 (57.9) | 0.77 (0.32-1.87) | 0.56 |
Long | 25 (44.6) | 16 (42.1) | (ref) | ||
Female | Short | 27 (64.3) | 13 (41.9) | 4.35 (1.20-15.74) | 0.03 |
Long | 15 (35.7) | 18 (58.1) | (ref) |
Odds ratio (95% confidence intervals);
includes orthopedic controls only from BDISO; ref = referent group;
adjusted for age and gender
adjusted for gender;
adjusted for age.